Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-14-058834

Chief Financial Officer sold 8,246 shares at $1.31 ($10,802)

From the SEC's structured data for this filing

Trades in this filing

Wheeler Patrick M · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2014-09-18 Sale : show line 1 in the form −8,246 $1.31 $10,802 101,510 D
Open-market sales · 8,246 sh · avg $1.31 · $10,802
Loading xslF345X03/doc4.xml…